The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Open accessAbstract
Surface-exposed calreticulin (ecto-CRT) and secreted ATP are crucial damage-associated molecular patterns (DAMPs) for immunogenic apoptosis. Inducers of immunogenic apoptosis rely on an endoplasmic reticulum (ER)-based (reactive oxygen species (ROS)-regulated) pathway for ecto-CRT induction, but the ATP secretion pathway is unknown. We found that after photodynamic therapy (PDT), which generates ROS-mediated ER stress, dying cancer cells undergo immunogenic apoptosis characterized by phenotypic maturation (CD80(high), CD83(high), CD86(high), MHC-II(high)) and functional stimulation (NO(high), IL-10(absent), IL-1β(high)) of dendritic cells as well as induction of a protective antitumour immune response. Intriguingly, early after PDT the cancer cells displayed ecto-CRT and secreted ATP before exhibiting biochemical signatures of apoptosis, through overlapping PERK-orchestrated pathways that require a functional secretory pathway and phosphoinositide 3-kinase (PI3K)-mediated plasma membrane/extracellular trafficking. Interestingly, eIF2α phosphorylation and caspase-8 signalling are dispensable for this ecto-CRT exposure. We also identified LRP1/CD91 as the surface docking site for ecto-CRT and found that depletion of PERK, PI3K p110α and LRP1 but not caspase-8 reduced the immunogenicity of the cancer cells. These results unravel a novel PERK-dependent subroutine for the early and simultaneous emission of two critical DAMPs following ROS-mediated ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with a key role of CALR in the immunogenicity of RCD, the RNAi-mediated knockdown of CALR as well as natural defects in the CALR exposure pathway reportedly abolish the ability of dying cancer cells succumbing to anthracyclines to establish protective immunity in mice, whereas the exogenous provision of recombinant CALR confers immunogenic properties to otherwise non-immunogenic variants”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [883]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Self-citationMinotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Photodynamic therapy and anti-tumour immunity
Castaño, A. P., Mróz, P., & Hamblin, M. R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1894 · Cited by 2,685
STRING 8--a global view on proteins and their functional interactions in 630 organisms
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C. J., Muller, J., Doerks, T., Julien, P., Roth, A. C., Simonovic, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn760 · Cited by 2,475
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Flagged first, then by citations
3 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Vergely C, Delemasure S, Cottin Y, Rochette L (2007) Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab 35: 1–7
Cited by
Sorted by citations
Items 501–600 of 800
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy
Xu, M. M., Pu, Y., Weichselbaum, R. R., & Fu, Y. (2016) · Oncogene · doi:10.1038/onc.2016.231 · Cited by 21
Klee, N., McCarthy, C. G., Quinones, P. M., & Webb, R. C. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717729141 · Cited by 23
Liu, L., Bai, J., Hu, L., & Jiang, D. (2023) · Medicine · doi:10.1097/md.0000000000035493 · Cited by 23
Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme
Koliaraki, V., Henriques, A. R., Prados, A., & Kollias, G. A. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190457 · Cited by 20
Gomes-da-Silva, L. C., Zhao, L., Arnaut, L. G., Kroemer, G., & Kepp, O. (2018) · Oncotarget · doi:10.18632/oncotarget.25798 · Cited by 20
Wen, W., Li, J., Shang, W., Zhuang, Z., Deng, X., Yan, X., Xie, D., Chen, C., Zhao, Z., Tang, B. Z., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101828 · Cited by 19
Lei, L., Dai, W., Zhao, J., Jiang, A., Peng, H., Jin, Q., Li, X., & Tang, Z. (2025) · Advanced Science · doi:10.1002/advs.202504860 · Cited by 19
DAMP signaling networks: from receptors to diverse pathophysiological functions
Chen, R., Zou, J., Zhong, X. Y., Liu, J., Kang, R., & Tang, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.047 · Cited by 26
Düzgün, M. B., Theofilatos, K., Georgakilas, A. G., & Pavlopoulou, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4606219 · Cited by 19
The “Yin and Yang” of Unfolded Protein Response in Cancer and Immunogenic Cell Death
Rufo, N., Yang, Y., Vleeschouwer, S. D., & Agostinis, P. (2022) · Cells · doi:10.3390/cells11182899 · Cited by 21
Self-citationChromomycin A5 induces bona fide immunogenic cell death in melanoma
Florêncio, K. G. D., Edson, E. A., Fernandes, K. S. D. S., Luiz, J. P. M., Pinto, F. D. C. L., Pessoa, O. D. L., Cunha, F. Q., Machado‐Neto, J. A., & Wilke, D. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941757 · Cited by 20
He, Y., Wang, C., Liang, Q., Guo, R., Jiang, J., Shen, W., & Hu, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1048978 · Cited by 19
Role of Natural Products in Combating Cancer
Barreto, C., & Jandus, A. (2022) · Cancer Insight · doi:10.58567/ci01010003 · Cited by 19
Immunogenicity of cancer cells: An overview
Singh, T., Bhattacharya, M., Mavi, A. K., Gulati, A., Rakesh, Sharma, N. K., Gaur, S., & Kumar, U. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110952 · Cited by 20
PERK and filamin A in actin cytoskeleton remodeling at ER-plasma membrane contact sites
van Vliet, A. R., & Agostinis, P. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1340105 · Cited by 19
Self-citationCoppard, C., Hannani, D., Humbert, M., Gauthier, V., Plumas, J., Merlin, É., Gabert, F. M., & Chaperot, L. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21698 · Cited by 19
Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
Garg, A. D., & Agostinis, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00110 · Cited by 20
Self-citationExpanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
Kimura, Y., Ghosn, M., Cheema, W., Adusumilli, P. S., Solomon, S. B., & Srimathveeralli, G. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.12.018 · Cited by 18
Mouratidis, P., & ter Haar, G. (2021) · International Journal of Hyperthermia · doi:10.1080/02656736.2021.1983036 · Cited by 17
Konda, P., Roque, J. A., Lifshits, L. M., Alcos, A., Azzam, E., Shi, G., Cameron, C. G., McFarland, S. A., & Gujar, S. A. (2022) · PubMed Central · Cited by 18
Redkin, T. S., Sleptsova, E. E., Turubanova, V. D., Saviuk, M. O., Lermontova, S. A., Klapshina, L. G., Peskova, N. N., Balalaeva, I. V., Krysko, O., Mishchenko, T. A., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102430 · Cited by 18
Self-citationZheng, Y., Yin, G., Le, V., Zhang, A., Lü, Y., Yang, M., Fei, Z., & Liu, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.036 · Cited by 17
Advancing Immunotherapy in Metastatic Breast Cancer
Mansour, M., Teo, Z. L., Luen, S. J., & Loi, S. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0478-9 · Cited by 17
Localized Microsphere/Hydrogel for Tumor Immunotherapy of Cardiac Glycoside with Minimal Toxicity
Gao, L., Zhao, M. L., Mao, Y., Zhang, L., Wang, X., Li, S., Qin, L., Xu, J. C., Hu, L., & Qiao, H. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18693 · Cited by 16
The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases
Eggleton, P., Alba, J. D., Weinreich, M. A., Calias, P., Foulkes, R., & Corrigall, V. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17669 · Cited by 16
Programing Immunogenic Cell Death in Breast Tumors with Designer DNA Frameworks
Tian, T., Zhao, B., Wei, H., Sun, M., Gao, Z., Lv, M., Lei, H., Ge, Z., & Ge, G. (2023) · JACS Au · doi:10.1021/jacsau.3c00099 · Cited by 16
Choi, J., Jang, H., Choi, J., Choi, Y., Yang, Y., Shim, M. K., & Kim, S. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.031 · Cited by 16
Ma, S., Veld, R. V. H. I. ‘., Houy, A., Stern, M., Rich, C. C., OSSENDORP, F. A., & Jager, M. J. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.7.10 · Cited by 16
Huang, W., He, Y., Yang, S., Xue, X., Qin, H., Sun, T., & Yang, W. (2023) · International Journal of Radiation Biology · doi:10.1080/09553002.2023.2235433 · Cited by 18
Significance of calreticulin as a prognostic factor in endometrial cancer
Xu, Q., Chen, C., Chen, G., Chen, W., Zhou, D., & Xie, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8495 · Cited by 16
Yuan, Y., Wang, Z., Yang, R., Qian, T., & Zhou, Q. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.051 · Cited by 16
Tham, M. J. R., Babak, M. V., & Ang, W. H. (2020) · Angewandte Chemie · doi:10.1002/ange.202008604 · Cited by 16
Fang, T., Ma, S., Wei, Y., Yang, J., Zhang, J., & Shen, Q. (2022) · Materials Today Chemistry · doi:10.1016/j.mtchem.2022.101308 · Cited by 16
Zhang, Y., Sultonova, R. D., You, S.-H., Choi, Y., Kim, S.-Y., Lee, W., Seong, J., Min, J., & Hong, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115473 · Cited by 16
Current status of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
Tran, T. H., & Tran, T. T. P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113085 · Cited by 15
Huang, P., Liang, S., Xiang, Y., Li, M., Wang, M., & Liu, L. (2024) · Small · doi:10.1002/smll.202311056 · Cited by 15
Teng, Y., Yang, Z., Peng, Y., Yang, Y., Chen, S., Li, J., Gao, D., Sun, W., Wu, Z., Zhou, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401851 · Cited by 15
Guo, Y., Jiang, T., Liang, S., Wang, A., Li, J., Jia, Y., Li, Q., Yin, J., Bai, S., & Li, J. (2025) · Advanced Science · doi:10.1002/advs.202412507 · Cited by 15
Tennant, I., Pound, J. D., Marr, L. A., Willems, J. J. L. P., Petrova, S., Ford, C. A., Paterson, M., Devitt, A., & Gregory, C. D. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.165 · Cited by 16
Jiang, W., Li, W., Hong, Y., Wang, S., & Fang, B. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1906-6 · Cited by 15
Mendlovic, F., Cruz-Rivera, M. Y., Díaz‐Gandarilla, J. A., Flores-Torres, M. A., Ávila, G., Perfiliev, M., Salazar, A. M., Arriaga‐Pizano, L., Ostrosky‐Wegman, P., & Flisser, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186510 · Cited by 22
Al-Karakooly, Z., Al-Anbaky, Q. A., Kannan, K., & Ali, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206182 · Cited by 15
Domka, K., Góral, A., & Firczuk, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01538 · Cited by 15
Self-citationNduwumwami, A. J., Hengst, J. A., & Yun, J. K. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000629 · Cited by 14
Wachowska, M., Osiak, A., Muchowicz, A., Gabrysiak, M., Domagała, A., Kilarski, W. W., & Gołąb, J. (2016) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2016.02.004 · Cited by 15
Yang, R., Wang, Z., Yuan, Y., Qian, T., & Zhou, Q. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.031 · Cited by 15
Liu, G., Qiu, Y., Zhang, P., Chen, Z., Chen, S., Huang, W., Wang, B., Yu, X., & Guo, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091762 · Cited by 14
Wang, C., Zhang, M., Peng, J., Zhang, M., Lu, C., Qi, X., Luo, Q., Wang, Y., & Li, G. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155504 · Cited by 14
Mishchenko, T. A., Balalaeva, I. V., Turubanova, V. D., Saviuk, M. O., Shilyagina, N. Y., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.05.003 · Cited by 16
Self-citationLi, Y., Zhu, J., Yang, Y., Chen, Y., Liu, L., Tao, J., Chen, H., & Deng, Y. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00746 · Cited by 13
Cifrić, S., Turi, M., Folino, P., Clericuzio, C., Barello, F., Maciel, T., Anderson, K. C., & Gullà, A. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0558 · Cited by 12
Zhang, T.-H., Zheng, Y., Xiang, H.-J., Chen, Y., & Wu, R. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102453 · Cited by 11
Immunopathogenesis of Sjogren's syndrome: Current state of DAMPs
Ming, B., Zhu, Y., Zhong, J., & Dong, L. (2022) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2022.152062 · Cited by 13
Targeted delivery of liposomal chemoimmunotherapy for cancer treatment
Liu, Y., Han, J., Yang, B., Bhatta, R., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010021 · Cited by 16
Lee, S. Y., Oh, J. Y., Kang, T. H., Shin, H. S., Cheng, M. A., Farmer, E. A., Wu, T. ‐., & Hung, C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0536-7 · Cited by 13
Villamañán, L., Martínez‐Escardó, L., Arús, C., Yuste, V. J., & Candiota, A. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073453 · Cited by 14
Schweinfurthin induces ICD without ER stress and caspase activation
Zhang, R., Neighbors, J. D., Schell, T. D., & Hohl, R. J. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2104551 · Cited by 13
Organic Semiconducting Polymers for Cancer Sonodynamic Immunotherapy
Hu, P., He, S., & Tian, H. (2025) · Polymer science & technology. · doi:10.1021/polymscitech.5c00112 · Cited by 12
Zou, J. X., Ivanov-Rostovtsev, P. A., Arakelyan, J., Babak, M. V., & Ang, W. H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18904 · Cited by 13
Mantareva, V. N., Braikova, D., Lazarova, I., & Genova, T. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2905168 · Cited by 12
Chen, J., Huang, J., Wang, Z., Song, X., Chen, Z., Zeng, Q., Zhou, X., Zuo, Z., Zhao, S., Chen, X., et al. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s163366 · Cited by 12
Research and application of hydrostatic high pressure in tumor vaccines (Review)
Yan, S., Liu, K., Mu, L., Liu, J., Tang, W., & Liu, B. (2021) · Oncology Reports · doi:10.3892/or.2021.8026 · Cited by 12
Bi, F., Jiang, Z., Park, W., Hartwich, T. M. P., Ge, Z., Chong, K. Y., Yang, K. B., Morrisson, M. J., Kim, D., Kim, J., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0396 · Cited by 12
In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol
Baert, T., Garg, A. D., VINDEVOGEL, E., Hoylandt, A. V., Verbist, G., Agonistinis, P., Vergote, I. B., & Coosemans, A. (2016) · Anticancer Research · doi:10.21873/anticanres.11163 · Cited by 12
Self-citationZenkoh, J., Gerelchuluun, A., Wang, Y., Miwa, Y., Ohno, T., & Tsuboi, K. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.01.32 · Cited by 12
Zhu, J., Jiang, R., Zhang, H., Fang, Z.-R., Zhou, H., Wei, Q., & Wang, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01705-7 · Cited by 12
Zheng, R., Chen, Z., Li, Q., Yang, N., Zhang, W., Huang, C., Zhao, L., Chen, X., Cheng, H., & Li, S. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110865 · Cited by 11
Bibliometric analysis of research on immunogenic cell death in cancer
Zhou, Y., Hu, F., Cui, Y., Wu, H., Hu, S., & Wei, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1029020 · Cited by 14
Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer
Bai, Y., Wang, W., Cheng, Y., & Yang, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01241-0 · Cited by 11
Photodynamic therapy in cancer stem cells — state of the art
Ibarra, A. M. C., Aguiar, E. M. G., Ferreira, C. B. R., Siqueira, J. M., Côrrea, L., Nunes, F. D., Franco, A. L. D. S., Cecatto, R. B., Hamblin, M. R., & Rodrigues, M. F. S. D. (2023) · Lasers in Medical Science · doi:10.1007/s10103-023-03911-1 · Cited by 11
Panzarini, E., Inguscio, V., Tenuzzo, B. A., & Dini, L. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213494552 · Cited by 12
Luo, W., Hoang, H., Miller, K. E., Zhu, H., Xu, S., Mo, X. M., Garfinkle, E. A. R., Costello, H. M., Wijeratne, S., Chemnitz, W., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03093-w · Cited by 10
Nanoscale metal–organic framework-mediated immunogenic cell death boosting tumor immunotherapy
Ni, W., Zhu, W., Wu, W., Chen, J., Ren, P., & Chen, F. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.111068 · Cited by 10
Kashefizadeh, A., & Kazemizadeh, H. (2022) · Clinical & Translational Oncology · doi:10.1007/s12094-022-02949-x · Cited by 10
Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
Wang, G., Liu, Y., Liu, S., Lin, Y., & Hu, C. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012647 · Cited by 10
Katahira, Y., Sakamoto, E., Watanabe, A., Furusaka, Y., Inoué, S., Hasegawa, H., Mizoguchi, I., Yo, K., Yamaji, F., Toyoda, A., et al. (2022) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2022.12.012 · Cited by 10
Gong, Z., Jia, Q., Guo, J., Li, C., Xu, S., Jin, Z., Chu, H., Wan, Y. Y., Zhu, B., & Zhou, Y. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00371-1 · Cited by 10
Nanoscale imaging of CD47 informs how plasma membrane modifications shape apoptotic cell recognition
Dufour, S., Tacnet‐Delorme, P., Kleman, J.-P., Glushonkov, O., Thielens, N. M., Bourgeois, D., & Frachet, P. (2023) · Communications Biology · doi:10.1038/s42003-023-04558-y · Cited by 10
The unfolding story of dying tumor cells during cancer treatment
He, S., Huang, Q., & Cheng, J. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1073561 · Cited by 10
Cell Death and Cancer, Novel Therapeutic Strategies
Grasso, S., Fernández-Pérez, M. P., Carrasco-Garca, E., Mayor-López, L., Tristante, E., Rocamora‐Reverte, L., Gmez-Martnez, N., García-Morales, P., Jos, A., Saceda, M., et al. (2012) · InTech eBooks · doi:10.5772/51285 · Cited by 10
Innate sensing of cancer's non-immunologic hallmarks
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.09.005 · Cited by 10
Cai, X., Feng, J., Chen, F., Guo, C., Sun, L., & Li, L. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101842 · Cited by 10
Elhassanny, A. E. M., Escobedo, R., Ladin, D. A., Burns, C., & Dross, R. V. (2020) · Oncotarget · doi:10.18632/oncotarget.27856 · Cited by 10
Immunogenic Cell Stress and Death Sensitize Tumors to Immunotherapy
Kepp, O., & Kroemer, G. (2023) · Cells · doi:10.3390/cells12242843 · Cited by 11
Gao, Y., Zhou, R., Wang, Q., Qi, S., Lv, Y., Liu, S., Shen, J., & Yu, G. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109521 · Cited by 9
Tan, Z., Zhang, L., Dai, W., Zhu, W., Wang, X., & Zhang, T. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123413 · Cited by 9
Xie, L., Chen, Z., Wang, T., Liang, J., Lie, Q., Jin, C., Zhang, X., Chen, Y., & Chao, H. (2025) · Chemical Science · doi:10.1039/d5sc04006j · Cited by 9
Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation
Inoue, H. (2026) · Viruses · doi:10.3390/v18040461 · Cited by 10
Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity
Qin, X., Denton, W. D., Huiting, L. N., Smith, K. S., & Feng, H. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1784085 · Cited by 9
He, M., Gu, W., Gao, Y., Liu, Y., Liu, J., & Li, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1043827 · Cited by 9
Towards Understanding the Molecular Mechanisms of Immunogenic Cell Death
Xiong, X., Wang, Y., & Zou, T. (2022) · ChemBioChem · doi:10.1002/cbic.202200621 · Cited by 9
Liu, X., Yao, S., Feng, Y., Li, P., Li, Y., & Xia, S. (2024) · Biomolecules · doi:10.3390/biom14010108 · Cited by 9
Cho, H., & Kim, K. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2348656 · Cited by 9
Cell Non-autonomous UPRER Signaling
Imanikia, S., Sheng, M., & Taylor, R. C. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_38 · Cited by 9
Lamy, D., Mouillot, P., Mariet, A., Barnestein, R., Quilot, F.-M., Fraisse, C., Ghiringhelli, F., Bonniaud, P., Zouak, A., & Foucher, P. (2024) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2024.101125 · Cited by 8
Xu, X., Sun, J., Zhao, J., Yu, F., Xu, Y., Zhang, C., & Li, J. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.09.225 · Cited by 8
Yan, Z., Cheng, H., Liu, Y., Xu, W., Cheng, Q., Li, L., Wu, X., Liang, Y., Zhao, J., Liu, G., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202522706 · Cited by 9
Li, L., Zhou, B., Xu, H., Shi, H., Gao, L., & Ge, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.872411 · Cited by 8
Hyperthermic intraperitoneal chemotherapy and colorectal cancer: From physiology to surgery
Ammerata, G., Filippo, R., Laface, C., Memeo, R., Solaini, L., Cavaliere, D., Navarra, G., Ranieri, G., Currò, G., & Ammendola, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i30.10852 · Cited by 8
From targeted therapy to a novel way: Immunogenic cell death in lung cancer
Xu, J., Xiong, Y., Xu, Z., Xing, H., Zhou, L., & Zhang, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1102550 · Cited by 10
Metadata
- Authors
- Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., & Agostinis, P.
- Affiliations
- KU Leuven (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Agostinis, Patrizia
- ORCID
- Venue
- The EMBO Journal
- Published
- 2012-01-17
- Volume
- 31
- Issue
- 5
- Pages
- 1062-1079
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC3298003
- OpenAlex
- W1942176190
- Cited by
- 800
- References
- 76
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 50 · 2023: 80 · 2022: 74 · 2021: 74 · 2020: 72 · 2019: 54 · 2018: 53 · 2017: 45 · 2016: 49 · 2015: 53 · 2014: 46 · 2013: 35 · 2012: 25
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- University of Alberta
- European Commission (200767)
- Fundacja na rzecz Nauki Polskiej
- Fonds De La Recherche Scientifique - FNRS
- Fonds Wetenschappelijk Onderzoek (G.0529.08)
- KU Leuven (GOA/11/009)
- Universiteit Gent (01M00709)
- Servier
- Vlaamse regering (BOF09/01M00709)
- European Regional Development Fund (POIG. 01.01.02-00-008/08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- calreticulin, ATP release, immunogenic cancer cell death, photodynamic therapy, reactive oxygen species, endoplasmic reticulum stress, PERK, phosphatidylinositol 3-kinase, damage-associated molecular patterns, dendritic cell maturation, antitumor immunity, caspase-8, eIF2α phosphorylation, secretory pathway
- MeSH terms
- CD83 Antigen, Adenosine Triphosphate, Histocompatibility Antigens Class II, Cell Line, Dendritic Cells, Endoplasmic Reticulum, Humans, Immunoglobulins, Membrane Glycoproteins, Neoplasms, Antigens, CD, Cell Death, Photosensitizing Agents, Reactive Oxygen Species, B7-1 Antigen, Calreticulin, B7-2 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review